In Ireland, US drugmaker MSD has opened its new facility in Dunboyne, County Meath, and has expanded its Carlow site. MSD says it has invested more than €1 billion at both sites, creating 670 new jobs and increasing the number of employees in Ireland to 3,100. 100 of the newly created positions remain to be filled.
PPG has completed an expansion of its powder coatings plant in Sumaré, Brazil. The $2.7 million project increased the production capacity of the facility by 40%. The unit is expected to reach full capacity this month.
US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies, combining Immatics’ TCR platform with Moderna’s mRNA technology. The project spans various therapeutic modalities including bispecifics, cell therapy and cancer vaccines.
The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.
Sanner, a German contract manufacturing and development organization (CDMO), is expanding its production capacity in the Asia-Pacific region with the opening of a second manufacturing facility in Kunshan, China.
Singapore-headquartered shipping company MOL Chemical Tankers has agreed to acquire the business of Fairfield Chemical Carriers, a subsidiary of Fairfield-Maxwell, in an all-cash transaction for about $400 million.
North American contract manufacturer Jubilant HollisterStier has appointed Ian Fuller as its new vice president of Operations.
Specialty chemicals and food ingredients distributor Azelis has appointed Evy Hellinckx as CEO of Azelis EMEA, effective Jan. 1, 2024. She succeeds Anna Bertona, who will take on her new role as Azelis Group CEO at the beginning of next year.
Brenntag started operations of its new personal care Innovation & Application Center in Lille, France.
In response to the urgent need for sustainable solutions in the surfactants industry, companies like Locus Ingredients are developing environmentally friendly biosurfactants.
In the dynamic realm of the chemical industry, surfactants serve as indispensable components with versatile applications, particularly in the home and personal care sector.
In this interview, Christene Smith sits down with Anne Lamp, the CEO & Co-Founder of Traceless Materials, to delve into the groundbreaking world of natural biopolymer materials.
Interview with Alban Chesneau and Nicolas Castet, Carbon Waters
The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.
The Egypt-based start-up Plastale produces composite materials for different applications out of local plastic and crop waste. Their recycling process aims to be energy and cost efficient, and the start-up focuses also on creating social impact through collaboration with local communities and local waste collectors. For this reason, International Sustainable Chemistry Collaborative Centre (ISC3) features Plastale as the ISC3 Start-up of the Month for September 2023.
US specialty ingredients and chemicals distributor Univar Solutions has acquired Canadian company FloChem and certain of its affiliates, giving Univar access to new market segments and new service capabilities. Terms of the transaction were not disclosed.
LyondellBasell plans to permanently close one of its two polypropylene (PP) plants at Brindisi, Italy, due to increasingly difficult market conditions and a poor outlook. The company has not disclosed which plant is affected, nor has it provided a timeline for the planned closure.
With the inauguration of a new research building in the Shanghai Technology Park, Solvay has completed the expansion of its China Research & Innovation Center (R&I). The company said that it has invested more than 4 billion RMB (approximately €500 million) in its Chinese R&I hub since 2005.
CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide production capacity with newly-upgraded facilities at its Colorado site in the US, which the company says is the world's largest solid-phase peptide synthesis (SPPS) manufacturing facility.
Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.
Australian lithium miner Liontown announced that it has received a revised conditional and non-binding indicative proposal from Albemarle to acquire all of the ordinary shares outstanding in Liontown for A$3.00 in cash per share via scheme of arrangement. The revised proposal values Liontown at A$6.6 billion ($4.3 billion) on an equity value basis.
The US Federal Trade Commission (FTC) wants to clear the takeover of Irish biotech company Horizon Therapeutics by pharmaceutical group Amgen. Following concessions by Amgen, the authority is dropping its earlier objections to the $27.8 billion purchase, the FTC announced last Friday.
Barentz has appointed Peter Boone as its new CEO, effective Oct. 1, 2023. He succeeds Hidde van der Wal, who is to retire after leading the company more than 20 years.
US science and technology group Danaher has entered into a definitive agreement to acquire Abcam, a supplier of life science research tools. Danaher will buy all of the outstanding shares of Abcam for $24.00 per share. The transaction, which is worth about $5.7 billion, is expected to close in mid-2024.
FEICA, the Association of the European Adhesive and Sealant Industry, will publish its latest study of the program “The European Adhesives and Sealants” on Sep. 14, 2023, at this year’s European Adhesive & Sealant Conference and Expo.
Austrian fibers producer Lenzing has completed technical improvements to its Purwakarta site in Indonesia. According to Lenzing, it has invested more than €100 million since 2021 to convert the location into a supplier of specialty viscose fibers.
Bayer’ Crop Science division plans to invest €220 million in a new research and development (R&D) facility at its Monheim, Germany site. This is the company’s largest single investment in its crop protection business in Germany since the founding of the Monheim campus in 1979, Bayer said.
Active pharmaceutical ingredients manufacturer EuroAPI has agreed to acquire BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides. Biano is to become a EuroAPI company but retain its corporate brand.
US drugstore chain CVS Health has launched Cordavis, a wholly owned subsidiary that will collaborate with manufacturers to commercialize and co-produce biosimilar products.
LG Chem, South Korea’s top chemicals manufacturer, plans to spend ₩124.6 billion (€86.9 million) to increase its water treatment material output capacity, aiming to double the business over the next 5 years.
Covestro has completed construction on a new production facility for polyurethane dispersions (PUDs) in Shanghai, China.
German CDMO Rentschler Biopharma is collaborating with the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization specializing in the advancement of cell and gene therapies, and Oxford-based mass photometry specialist Refeyn, to improve the manufacturing adeno-associated viruses (AAVs).
Kenvue, the world’s largest pure-play consumer health company by revenue and maker of brands such as Band-Aid, Tylenol, Listerine or Neutrogena, eventually became a fully independent company following the final separation from Johnson & Johnson. A stock swap offer to exchange shares of Johnson & Johnson common stock for shares of Kenvue ended at the end of the day on Aug. 18, 2023.
Cellares, a US-based integrated development and manufacturing organization (IDMO), has secured $255 million in Series C funding to establish a cell therapy development facility in Bridgewater, New Jersey.
Cheniere Energy and BASF signed a long-term liquefied natural gas (LNG) sale and purchase agreement (SPA).
